Mail

UK markets close in 1 hour 40 minutes

FTSE 100
8,217.03
-30.76(-0.37%)
FTSE 250
20,284.76
-78.67(-0.39%)
AIM
765.65
-2.38(-0.31%)
GBP/EUR
1.1837
-0.0001(-0.01%)
GBP/USD
1.2635
-0.0051(-0.40%)
Bitcoin GBP
48,845.14
+316.38(+0.65%)

The cost of following England at Euro 2024

What could your money earn if you invested your football spending elsewhere

Jinhe Biotechnology CO., LTD. (002688.SZ)

Shenzhen - Shenzhen Delayed price. Currency in CNY

Add to watchlist

3.7000

+0.0900

(+2.49%)

At close: 03:04PM CST

Currency in CNY

Valuation measures⁴

Market cap (intra-day)	2.82B
Enterprise value	4.60B
Trailing P/E	29.76
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	1.30
Price/book (mrq)	1.25
Enterprise value/revenue	2.12
Enterprise value/EBITDA	43.66

Trading information

Stock price history

Beta (5Y monthly)	0.41
52-week change ³	-19.42%
S&P500 52-week change ³	24.96%
52-week high ³	5.2000
52-week low ³	2.9100
50-day moving average ³	4.1788
200-day moving average ³	4.4211

Share statistics

Avg vol (3-month) ³	16.85M
Avg vol (10-day) ³	8.45M
Shares outstanding ⁵	780.42M
Implied shares outstanding ⁶	780.42M
Float ⁸	474.67M
% held by insiders ¹	44.52%
% held by institutions ¹	5.84%
Shares short ⁴	N/A
Short ratio ⁴	N/A
Short % of float ⁴	N/A
Short % of shares outstanding ⁴	N/A
Shares short (prior month ) ⁴	N/A

Dividends & splits

Forward annual dividend rate ⁴	0.1
Forward annual dividend yield ⁴	2.77%
Trailing annual dividend rate ³	0.10
Trailing annual dividend yield ³	2.77%
5-year average dividend yield ⁴	2.53
Payout ratio ⁴	82.44%
Dividend date ³	N/A
Ex-dividend date ⁴	31 May 2024
Last split factor ²	25:10
Last split date ³	17 May 2016

Financial highlights

Fiscal year

Fiscal year ends	31 Dec 2023
Most-recent quarter (mrq)	31 Mar 2024

Profitability

Profit margin	4.37%
Operating margin (ttm)	13.83%

Management effectiveness

Return on assets (ttm)	1.97%
Return on equity (ttm)	4.07%

Income statement

Revenue (ttm)	2.17B
Revenue per share (ttm)	2.78
Quarterly revenue growth (yoy)	-1.50%
Gross profit (ttm)	N/A
EBITDA	338.51M
Net income avi to common (ttm)	94.68M
Diluted EPS (ttm)	0.1200
Quarterly earnings growth (yoy)	22.30%

Balance sheet

Total cash (mrq)	660.74M
Total cash per share (mrq)	0.87
Total debt (mrq)	2.44B
Total debt/equity (mrq)	96.48%
Current ratio (mrq)	1.02
Book value per share (mrq)	2.96

Cash flow statement

Operating cash flow (ttm)	293.51M
Levered free cash flow (ttm)	-163.06M